| Literature DB >> 28441343 |
Yon-Suk Kim1,2, Eun-Kyung Kim3, Weligala Pahalagedara Amila Srilal Nawarathna4, Xin Dong5, Woen-Bin Shin6, Jin-Su Park7, Sang-Ho Moon8, Pyo-Jam Park9,10.
Abstract
Althaea rosea (Linn.) is a medicinal plant from China and Korea that has been traditionally used to control inflammation, to stop bedwetting and as a mouthwash in cases of bleeding gums. Its flowers are employed medicinally for their emollient, demulcent and diuretic properties, which make them useful in chest complaints. Furthermore, a flower extract decoction is used to improve blood circulation, for the treatment of constipation, dysmenorrhoea, haemorrhages, etc. However, the possible mechanisms of the immune-stimulatory effect remains to be elucidated. Therefore, we investigated the role of Althaea rosea flower (ARF) extracts in the immune-stimulatory effect of macrophages and the underlying mechanisms of action. ARF water extract (ARFW) could dose-dependently increase NO production and cytokines (IL-6 and TNF-α). We also found that ARFW significantly increased the expression of iNOS and COX-2 proteins in RAW264.7 cells. Consistent with these results, MAPK protein (JNK, ERK, p38) expression levels were induced after treatment with ARFW. Additionally, ARFW showed a marked increase in the phosphorylation level of IκBα and subsequent IκBα degradation allowing NF-κB nuclear translocation. These results suggest that the immune-stimulatory effect of A. rosea flower extracts is mediated through the translocation of NF-κB p65 subunit into the nucleus from the cytoplasm and subsequent activation of pro-inflammatory cytokines (IL-6 and TNF-α) and other mediators (iNOS and COX-2), which occurs mainly through MAPK signalling pathway. Thus, we suggest that ARFW could be considered as a potential therapeutic agent useful in the development of immune-stimulatory compounds.Entities:
Keywords: Althaea rosea; RAW264.7 cells; immune-stimulatory effect
Mesh:
Substances:
Year: 2017 PMID: 28441343 PMCID: PMC6154003 DOI: 10.3390/molecules22050679
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1A. rosea flower extracts were not toxic to murine macrophage RAW264.7 cells (A) A. rosea flower water extracts (ARFW) induced the production of NO; (B) The cell viability was determined by MTT assay. ARFW, ARFE and lipopolysaccharide (LPS, 100 ng/mL) showed no cytotoxicity on RAW264.7 cells with 100 μg/mL maximum concentration for 24 h. NO production was induced by ARFW, but not by ARFE. ** p < 0.01, *** p < 0.001 vs. control.
Figure 2ARFW increased the release of cytokines (IL-6 (A); TNF-α (B)). The production of cytokines was determined by ELISA assay. All values are expressed as the means ± S.D. *** p < 0.001 vs control.
Figure 3ARFW induced iNOS and COX-2 protein expression. Cells were treated with ARFW or LPS (100 ng/mL) for 18 h and protein expression levels were determined by western blot analysis with specific antibodies.
Figure 4Effect of ARFW on NF-kB activity in RAW264.7 cells. Cells were treated with ARFW or LPS (100 ng/mL) for 15 min. Total cellular proteins were prepared and subjected to western blot analysis for determination of IκBα and p-IκBα protein levels. Nuclear (N) and cytosolic (C) proteins were isolated, and the levels of p65 were determined by Western blot analysis.
Figure 5Effect of ARFW on MAPK signaling. Cells were treated with ARFW or LPS (100 ng/mL) for 30 min and MAPK protein expression levels were determined by western blot analysis with specific antibodies (A). Cells were treated with ARFW or LPS (100 ng/mL) in the presence of MAPK inhibitors for 30 min and MAPK protein expression levels were determined, Cells were treated with 20 μM of the MAPK inhibitor SB203580 (p38 inhibitor), SP600125 (JNK inhibitor), and PD098059 (ERK inhibitor) (B,C).